Literature DB >> 25326897

In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9.

Lukasz Swiech1, Matthias Heidenreich1, Abhishek Banerjee2, Naomi Habib1, Yinqing Li3, John Trombetta4, Mriganka Sur2, Feng Zhang1.   

Abstract

Probing gene function in the mammalian brain can be greatly assisted with methods to manipulate the genome of neurons in vivo. The clustered, regularly interspaced, short palindromic repeats (CRISPR)-associated endonuclease (Cas)9 from Streptococcus pyogenes (SpCas9) can be used to edit single or multiple genes in replicating eukaryotic cells, resulting in frame-shifting insertion/deletion (indel) mutations and subsequent protein depletion. Here, we delivered SpCas9 and guide RNAs using adeno-associated viral (AAV) vectors to target single (Mecp2) as well as multiple genes (Dnmt1, Dnmt3a and Dnmt3b) in the adult mouse brain in vivo. We characterized the effects of genome modifications in postmitotic neurons using biochemical, genetic, electrophysiological and behavioral readouts. Our results demonstrate that AAV-mediated SpCas9 genome editing can enable reverse genetic studies of gene function in the brain.

Entities:  

Mesh:

Year:  2014        PMID: 25326897      PMCID: PMC4492112          DOI: 10.1038/nbt.3055

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  42 in total

1.  Developments in neuronal cell culture.

Authors:  G Banker; K Goslin
Journal:  Nature       Date:  1988-11-10       Impact factor: 49.962

2.  Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons.

Authors:  Jian Feng; Yu Zhou; Susan L Campbell; Thuc Le; En Li; J David Sweatt; Alcino J Silva; Guoping Fan
Journal:  Nat Neurosci       Date:  2010-03-14       Impact factor: 24.884

3.  Optimizing promoters for recombinant adeno-associated virus-mediated gene expression in the peripheral and central nervous system using self-complementary vectors.

Authors:  Steven J Gray; Stacey B Foti; Joel W Schwartz; Lavanya Bachaboina; Bonnie Taylor-Blake; Jennifer Coleman; Michael D Ehlers; Mark J Zylka; Thomas J McCown; R Jude Samulski
Journal:  Hum Gene Ther       Date:  2011-06-01       Impact factor: 5.695

4.  Effect of genome size on AAV vector packaging.

Authors:  Zhijian Wu; Hongyan Yang; Peter Colosi
Journal:  Mol Ther       Date:  2009-11-10       Impact factor: 11.454

5.  Dissection of hippocampal dentate gyrus from adult mouse.

Authors:  Hideo Hagihara; Keiko Toyama; Nobuyuki Yamasaki; Tsuyoshi Miyakawa
Journal:  J Vis Exp       Date:  2009-11-17       Impact factor: 1.355

6.  Synaptic circuit abnormalities of motor-frontal layer 2/3 pyramidal neurons in an RNA interference model of methyl-CpG-binding protein 2 deficiency.

Authors:  Lydia Wood; Noah W Gray; Zhaolan Zhou; Michael E Greenberg; Gordon M G Shepherd
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

7.  Permanent alteration of PCSK9 with in vivo CRISPR-Cas9 genome editing.

Authors:  Qiurong Ding; Alanna Strong; Kevin M Patel; Sze-Ling Ng; Bridget S Gosis; Stephanie N Regan; Chad A Cowan; Daniel J Rader; Kiran Musunuru
Journal:  Circ Res       Date:  2014-06-10       Impact factor: 17.367

8.  Adult neural function requires MeCP2.

Authors:  Christopher M McGraw; Rodney C Samaco; Huda Y Zoghbi
Journal:  Science       Date:  2011-06-02       Impact factor: 47.728

9.  The UCSC Genome Browser database: update 2011.

Authors:  Pauline A Fujita; Brooke Rhead; Ann S Zweig; Angie S Hinrichs; Donna Karolchik; Melissa S Cline; Mary Goldman; Galt P Barber; Hiram Clawson; Antonio Coelho; Mark Diekhans; Timothy R Dreszer; Belinda M Giardine; Rachel A Harte; Jennifer Hillman-Jackson; Fan Hsu; Vanessa Kirkup; Robert M Kuhn; Katrina Learned; Chin H Li; Laurence R Meyer; Andy Pohl; Brian J Raney; Kate R Rosenbloom; Kayla E Smith; David Haussler; W James Kent
Journal:  Nucleic Acids Res       Date:  2010-10-18       Impact factor: 16.971

10.  Optical control of mammalian endogenous transcription and epigenetic states.

Authors:  Silvana Konermann; Mark D Brigham; Alexandro Trevino; Patrick D Hsu; Matthias Heidenreich; Le Cong; Randall J Platt; David A Scott; George M Church; Feng Zhang
Journal:  Nature       Date:  2013-08-23       Impact factor: 49.962

View more
  330 in total

1.  Induction of Brain Arteriovenous Malformation Through CRISPR/Cas9-Mediated Somatic Alk1 Gene Mutations in Adult Mice.

Authors:  Wan Zhu; Daniel Saw; Miriam Weiss; Zhengda Sun; Meng Wei; Sonali Shaligram; Sen Wang; Hua Su
Journal:  Transl Stroke Res       Date:  2018-12-03       Impact factor: 6.829

2.  Use of Adeno-Associated and Herpes Simplex Viral Vectors for In Vivo Neuronal Expression in Mice.

Authors:  Rachel D Penrod; Audrey M Wells; William A Carlezon; Christopher W Cowan
Journal:  Curr Protoc Neurosci       Date:  2015-10-01

Review 3.  Combining CRISPR/Cas9 and rAAV Templates for Efficient Gene Editing.

Authors:  Manuel Kaulich; Steven F Dowdy
Journal:  Nucleic Acid Ther       Date:  2015-11-05       Impact factor: 5.486

4.  Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cells.

Authors:  Jia Liu; Thomas Gaj; Yifeng Yang; Nan Wang; Sailan Shui; Sojung Kim; Chidananda Nagamangala Kanchiswamy; Jin-Soo Kim; Carlos F Barbas
Journal:  Nat Protoc       Date:  2015-10-22       Impact factor: 13.491

Review 5.  Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery.

Authors:  Mehmet Fatih Bolukbasi; Ankit Gupta; Scot A Wolfe
Journal:  Nat Methods       Date:  2016-01       Impact factor: 28.547

Review 6.  Optogenetic tools for modulating and probing the epileptic network.

Authors:  Mingrui Zhao; Rose Alleva; Hongtao Ma; Andy G S Daniel; Theodore H Schwartz
Journal:  Epilepsy Res       Date:  2015-06-21       Impact factor: 3.045

7.  Targeted Delivery of CRISPR/Cas9-Mediated Cancer Gene Therapy via Liposome-Templated Hydrogel Nanoparticles.

Authors:  Zeming Chen; Fuyao Liu; Yanke Chen; Jun Liu; Xiaoying Wang; Ann T Chen; Gang Deng; Hongyi Zhang; Jie Liu; Zhangyong Hong; Jiangbing Zhou
Journal:  Adv Funct Mater       Date:  2017-10-16       Impact factor: 18.808

8.  Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors.

Authors:  Silvana Konermann; Peter Lotfy; Nicholas J Brideau; Jennifer Oki; Maxim N Shokhirev; Patrick D Hsu
Journal:  Cell       Date:  2018-03-15       Impact factor: 41.582

Review 9.  CRISPR-Cas9: A multifaceted therapeutic strategy for cancer treatment.

Authors:  Itishree Kaushik; Sharavan Ramachandran; Sanjay K Srivastava
Journal:  Semin Cell Dev Biol       Date:  2019-05-04       Impact factor: 7.727

Review 10.  Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.

Authors:  Joshua Kuruvilla; Andrew Octavian Sasmita; Anna Pick Kiong Ling
Journal:  Neurol Sci       Date:  2018-08-03       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.